CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $216M invested in Cymabay Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 24
31% less call options, than puts
Call options by funds: $1.38M | Put options by funds: $1.99M
Holders
113
Holding in Top 10
6
Calls
$1.38M
Puts
$1.99M
Top Buyers
| 1 | +$6.76M | |
| 2 | +$5.92M | |
| 3 | +$4.27M | |
| 4 |
CC
Commodore Capital
New York
|
+$4.22M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$3.79M |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$1.1M | |
| 3 | -$1M | |
| 4 |
Two Sigma Advisers
New York
|
-$665K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$420K |